Compare BLK & SYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BLK | SYK |
|---|---|---|
| Founded | 1988 | 1941 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 163.6B | 141.2B |
| IPO Year | 1999 | N/A |
| Metric | BLK | SYK |
|---|---|---|
| Price | $1,066.91 | $365.67 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 11 |
| Target Price | ★ $1,259.60 | $433.91 |
| AVG Volume (30 Days) | 812.0K | ★ 2.2M |
| Earning Date | 01-15-2026 | 01-29-2026 |
| Dividend Yield | ★ 2.14% | 0.96% |
| EPS Growth | N/A | ★ 8.25 |
| EPS | ★ 35.31 | 8.40 |
| Revenue | $24,216,000,000.00 | ★ $25,116,000,000.00 |
| Revenue This Year | $17.53 | $9.82 |
| Revenue Next Year | $10.44 | $8.42 |
| P/E Ratio | ★ $30.35 | $43.58 |
| Revenue Growth | ★ 18.66 | 11.16 |
| 52 Week Low | $773.74 | $329.16 |
| 52 Week High | $1,219.94 | $404.87 |
| Indicator | BLK | SYK |
|---|---|---|
| Relative Strength Index (RSI) | 39.43 | 64.69 |
| Support Level | $1,017.00 | $355.78 |
| Resistance Level | $1,113.56 | $369.31 |
| Average True Range (ATR) | 34.74 | 9.27 |
| MACD | -6.29 | 1.27 |
| Stochastic Oscillator | 28.12 | 97.53 |
BlackRock is the largest asset manager in the world, with $14.041 trillion in assets under management at the end of December 2025. Its product mix is diverse, with 55% of managed assets in equity strategies, 23% in fixed income, 9% in multi-asset classes, 6% in money market funds, and 5% in alternatives. Passive strategies account for more than two-thirds of long-term AUM, with the company's ETF platform maintaining a leading market share domestically and on a global basis. Product distribution is weighted more toward institutional clients, which, by our calculations, account for around 80% of AUM. BlackRock is geographically diverse, with clients in more than 100 countries and more than one-third of managed assets coming from investors domiciled outside the US and Canada.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.